ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Science

Japan approves first trials of stem cell-based heart treatment

iPS procedure raises hopes for alternative to donations and artificial organs

Osaka University professor Yoshiki Sawa outlines his plans for treating heart failure in 2017. (Photo by Hiromasa Matsuura)
Nikkei staff writers | Japan

TOKYO -- Japan is set to host the world's first clinical trials involving the use of induced pluripotent stem (iPS) cells to treat heart failure. 

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close